Virion

The viral infection was confirmed by the presence of the virion in the patient's respiratory secretions.

The epidemiologist traced the transmission of the virion in a community outbreak.

The virologist isolated the virion from the patient's blood sample.

The host immune system recognizes and destroys the invading virion.

The transmission of the virion from one host to another occurs through close contact.

The researchers studied the genetic material contained within the virion.

The antiviral drug prevents the assembly of the virion in infected cells.

The team of scientists developed a vaccine that targets the outer shell of the virion.

The outer lipid envelope of the virion helps protect the viral genome during transmission.

The vaccine targets the specific proteins on the surface of the virion.

The researcher studied the structure and composition of the HIV virion.

The virologist isolated a single virion from the patient's blood sample.

The virion mutates rapidly, making it difficult to develop a single effective vaccine.

The high mutation rate of the virion makes it challenging to develop effective antiviral drugs.

The virologist discovered a novel virion in a remote jungle.

The virion attaches itself to host cells during the infection process.

The researcher studied the fusion mechanism of the virion with host cells.

The patient's symptoms are a result of the virion spreading throughout their body.

The DNA sequence of the virion matched that of the parent virus.

The laboratory technician is analyzing the size and shape of the virion.

Researchers are trying to develop antiviral drugs that can inhibit the replication of the virion.

The scientist is studying the genetic material inside the virion.

The presence of a defective virion can interfere with viral replication.

The study analyzed the kinetics of virion release from infected cells, providing insights into viral replication.

The vaccine targets the surface proteins of the virion, preventing it from entering host cells.

The diagnostic test detected the presence of the virion in the patient's saliva.

The antiviral drug disrupts the replication of the virion, inhibiting its ability to infect new cells.

The researchers studied the structure of the virion to understand its replication process.

The doctor explained that the virion was responsible for causing the flu.

The technician successfully isolated the virion from the patient's blood sample.

The virologist identified the virion as a new strain of the virus.

The scientist observed the assembly of the virion in the laboratory, noting its formation step by step.

The antiviral drug worked by inhibiting the replication of the virion in the host cells.

The virologist examined the surface glycoproteins of the virion, which play a crucial role in host recognition.

The transmission of the virion from one person to another caused the spread of the disease.

The technician used a special dye to stain the virion for better visibility.

The epidemiologist traced the spread of the virion through a community.

The technician used a special technique to isolate the virion from the patient's blood sample.

The researcher isolated the virion from the patient's blood sample.

The doctor explained that the virion was responsible for the patient's symptoms.

The researcher studied the structure of the virion to better understand its mechanism of infection.

The pathologist identified the presence of the virion in the tissue sample, confirming the viral infection.

The virion attaches to specific receptors on the host cell to initiate infection.

The pharmaceutical company developed a drug that could inhibit the replication of the virion.

The scientists studied the interaction between the virion and the host immune system.

The study focused on the genetic composition of the virion and its impact on disease transmission.

The virion attaches to specific receptors on the host cell surface to initiate infection.

The size and shape of the virion can vary depending on the virus species.

The virion enters the host cell and releases its genetic material.

The vaccine targets the surface proteins of the virion to elicit an immune response.